PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM
Total 13F shares
35,010,158
Share change
-904,597
Total reported value
$160,247,214
Put/Call ratio
2103%
Price per share
$4.58
Number of holders
41
Value change
-$3,537,793
Number of buys
18
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q1 2014

As of 31 Mar 2014, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,010,158 shares. The largest 10 holders included FEDERATED INVESTORS INC /PA/, Allianz Asset Management AG, BAILLIE GIFFORD & CO, Camber Capital Management LLC, BlackRock Advisors LLC, DAFNA Capital Management LLC, FMR LLC, GREAT POINT PARTNERS LLC, MENORA MIVTACHIM HOLDINGS LTD., and Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management). This page lists 41 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.